Table 2 Risk factors for the development of invasive candidal infection
From: Prediction of invasive candidal infection in critically ill patients with severeacute pancreatitis
| Â | Patients without invasive candidal infection | Patients with invasive candidal infection | P value |
|---|---|---|---|
Patients, number | 83 | 18 | Â |
Severe sepsis on admission to ICU, number (%) | 30 (36.1) | 7 (38.9) | 0.999 |
CVC, number (%) | 74 (89.2) | 17 (94.4) | 0.686 |
Antibiotics, number (%) | 53 (63.9) | 14 (77.8) | 0.409 |
Renal replacement therapy, number (%) | 14 (16.9) | 4 (22.2) | 0.734 |
Steroids, number (%) | 34 (41) | 7 (38.9) | 0.999 |
Immunosuppressive drugs, number (%) | 2 (2.4) | 2 (11.1) | 0.145 |
Surgery, number (%) | 22 (26.5) | 7 (38.9) | 0.389 |
TPN, number (%) | 26 (31.3) | 8 (44.4) | 0.288 |
Significant pancreatic necrosis, number (%) | 40 (48.2) | 13 (72.2) | 0.063 |
Positive blood culture, number (%) | 28 (33.7) | 8 (44.4) | 0.424 |
Colonised with candida, number (%) | 37 (44.6) | 16 (88.9) | >0.001 |